News

Roche said that the phase 3 PEMPHIX trial of MabThera (rituximab) in moderate to severe pemphigus vulgaris (PV) met its primary endpoint at Week 52. The PEMPHIX trial also showed that MabThera was superior to mycophenolate mofetil (MMF) in the...

Health Gorilla, a leader in clinical data APIs, and WellVia, a premier telehealth company, announced a partnership that enables new data exchange capabilities within the WellVia telehealth platform. WellVia will utilize Health Gorilla's FHIR APIs to equip healthcare providers...

CPhI Worldwide, 5–7 November in Frankfurt a.M., is the perfect place to make new business contacts, strengthen existing relationships, discover state-of-the-art ingredients and meet BENEO’s expert team. Taking center stage on stand 102C11 is the company’s high quality, water-soluble...

STA Pharmaceutical Co Ltd – a subsidiary of WuXi AppTec – announced that its Jinshan manufacturing facility in Shanghai, China has successfully passed an inspection by the European Medicines Agency (EMA) with no critical and no major findings. This...

Turkish Cargo, the fastest-growing brand of the global air cargo industry, updated its web portal; a functional and user-friendly interface on Internet facilitating monitoring of all actions and providing the agents with customized solutions and facilitations. The renewed web portal...

CPhI Worldwide – the world’s largest pharma event taking place in Frankfurt (5th-7th November 2019) –has released the first part of its eponymous2019 Annual Report. Experts Bikash Chatterjee, President and Chief Science Officer at Pharmtech Associates and Girish Malhotra,...

Japanese pharmaceutical firm Shionogi has signed a licence agreement with Hsiri Therapeutics for the discovery and development of therapies for non-tuberculous mycobacterial (NTM) diseases, as well as tuberculosis (TB). The agreement covers a technology that will complement the company’s previous...